VYNE THERAPEUTICS INC (VYNE) Earnings History & Surprises
NASDAQ:VYNE • US92941V3087
0.5825 USD
-0.01 (-1.75%)
At close: Mar 5, 2026
0.5813 USD
0 (-0.21%)
After Hours: 3/5/2026, 8:26:21 PM
Past quarterly earnings results for VYNE THERAPEUTICS INC (VYNE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.18
Revenue Estimate204K
Last Reported
Release DateFeb 27, 2026
PeriodQ4 / 2025
EPS Reported
EPS Surprise %
Revenue Surprise -36.27%
Beat Rate
25%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.18 | - | 34.43% | 130K | 204K | -36.27% | 54.76% | |
| Q3 2025 | -0.17 | -0.13 | -28.21% | 41.38% | 169K | 102K | 65.69% | 39.67% |
| Q2 2025 | -0.13 | -0.23 | 42.93% | 40.91% | 69K | 153K | -54.90% | -65.15% |
| Q1 2025 | -0.20 | -0.30 | 32.39% | -33.33% | 202K | 51K | 296.08% | 106.12% |
| Q4 2024 | -0.28 | -0.31 | 9.50% | -40.00% | 84K | 142.8K | -41.18% | 10.53% |
| Q3 2024 | -0.29 | -0.24 | -20.98% | 85.57% | 121K | 112.2K | 7.84% | 6.14% |
| Q2 2024 | -0.22 | -0.19 | -13.52% | 92.88% | 198K | 112.2K | 76.47% | 46.67% |
| Q1 2024 | -0.15 | -0.24 | 38.73% | 91.38% | 98K | 102K | -3.92% | -1.01% |
| Q4 2023 | -0.20 | -0.51 | 60.78% | 93.99% | 76K | 153K | -50.33% | 660.00% |
| Q3 2023 | -2.01 | -0.78 | -159.29% | 30.21% | 114K | 153K | -25.49% | -32.94% |
| Q2 2023 | -3.09 | -2.03 | -52.23% | -32.05% | 135K | 102K | 32.35% | 3.85% |
| Q1 2023 | -1.74 | -2.66 | 34.64% | 30.95% | 99K | - | -45.00% | |
| Q4 2022 | -3.33 | -3.30 | -0.76% | 7.50% | 10K | 61.2K | -83.66% | 100.27% |
| Q3 2022 | -2.88 | -3.18 | 9.50% | 55.56% | 170K | 135.997K | 25.00% | -95.84% |
| Q2 2022 | -2.34 | -3.12 | 25.03% | 62.86% | 130K | 102K | 27.45% | -56.67% |
| Q1 2022 | -2.52 | -3.03 | 16.82% | 62.16% | 180K | 374.003K | -51.87% | -21.74% |
| Q4 2021 | -3.60 | -4.35 | 17.15% | 63.64% | -3.68M | 4.208M | -187.45% | -185.78% |
| Q3 2021 | -6.48 | -5.92 | -9.44% | 40.00% | 4.09M | 4.857M | -15.79% | 25.08% |
| Q2 2021 | -6.30 | -6.50 | 3.07% | 56.25% | 300K | 7.682M | -96.09% | -97.43% |
| Q1 2021 | -6.66 | -7.49 | 11.09% | 90.26% | 230K | 5.413M | -95.75% | -86.86% |
| Q4 2020 | -9.90 | -9.84 | -0.60% | - | 4.29M | 4.801M | -10.64% | - |
| Q3 2020 | -10.80 | -12.27 | 12.01% | - | 3.27M | 3.318M | -1.45% | - |
| Q2 2020 | -14.40 | -18.24 | 21.04% | - | 11.69M | 2.472M | 372.90% | - |
| Q1 2020 | -68.40 | -39.66 | -72.48% | - | 1.75M | 2.22M | -21.17% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
67.65%
Max Revenue beat (4)
296.08%
Min Revenue beat (4)
-54.90%
Analysis
VYNE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, VYNE has beaten the revenue estimates by 67.6% on average.
VYNE THERAPEUTICS INC / VYNE Earnings FAQ
What is the most recent earnings date for VYNE stock?
VYNE THERAPEUTICS INC (VYNE) last reported earnings on 2/27/2026.
Can you provide information on whether VYNE THERAPEUTICS INC beat earnings estimates in the last quarter?
VYNE THERAPEUTICS INC (VYNE) missed EPS estimates and missed revenue estimates in the most recent quarter.